ClinicalTrials.Veeva

Menu

Exertional Rhabdomyolysis- Characterization of Prediction Tests for Return to Duty

S

Sheba Medical Center

Status

Unknown

Conditions

Rhabdomyolysis

Treatments

Other: physical tests

Study type

Interventional

Funder types

Other

Identifiers

NCT02498366
2388-15-SMC

Details and patient eligibility

About

In order to determine norm values for skeleton muscle disassembly due to physical exertion in healthy and trained population, and developing a prediction test for approval for rhabdomyolysis injuries to return to duty, 50 healthy subjects will undergo a series of different physical tests.

Full description

50 healthy civilians volunteers will be recruited for this study. Each subject will undergo the physical tests: anthropometric measurements, wingate test, VO2max test, step test and running on the anaerobic threshold, on separate days. Blood sample, lactic acid level (measured in blood drop - finger sting) and urine sample will be taken before and after every test.

Enrollment

50 estimated patients

Sex

Male

Ages

18 to 30 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • healthy civilians ages 18-30.
  • above average aerobic and anaerobic fitness.
  • Without heart, cardiovascular, metabolic or respiratory illnesses.
  • Without known medical illness or medication use that might endanger the participants.

Exclusion criteria

  • existence of any of undesired conditions detailed in the inclusion criteria.
  • the physician decision.

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

50 participants in 1 patient group

experimental protocol
Experimental group
Description:
50 healthy, male, trained and aged 18-30 will be recruited and asked to undergo a series of physical tests.
Treatment:
Other: physical tests

Trial contacts and locations

1

Loading...

Central trial contact

Ofir Frenkel, M.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems